Stock 6547 MEDIGEN VACCINE BIOLOGICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
51.3 TWD -1.35% Intraday chart for Medigen Vaccine Biologics Corporation +5.77% -26.82%
Mar. 15 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,443 4,447 21,743 63,653 22,785 23,035
Enterprise Value (EV) 1 5,248 4,781 20,198 61,606 20,504 21,253
P/E ratio -11 x -7.18 x -28.6 x 45.4 x -15.2 x -19.8 x
Yield - - - - - -
Capitalization / Revenue - 3,970,297,998 x 1,889,560,351 x 19,400,542 x 62,417,127 x 59,122,190 x
EV / Revenue - 4,268,548,891 x 1,755,310,764 x 18,776,666 x 56,167,962 x 54,546,582 x
EV / EBITDA -14.4 x -9.61 x -30.9 x 57.5 x -14.4 x -19.4 x
EV / FCF -23.3 x -16.1 x -36.4 x -214 x -27.5 x -129 x
FCF Yield -4.29% -6.2% -2.75% -0.47% -3.63% -0.77%
Price to Book 3.38 x 3.25 x 6.92 x 13.6 x 4.53 x 5.99 x
Nbr of stocks (in thousands) 230,612 231,356 313,018 315,669 327,840 328,608
Reference price 2 23.60 19.22 69.46 201.6 69.50 70.10
Announcement Date 3/29/19 3/31/20 3/11/21 3/11/22 3/15/23 3/15/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - 1.12 11.51 3,281 365 389.6
EBITDA 1 -365.5 -497.4 -653.8 1,072 -1,423 -1,098
EBIT 1 -466.3 -603.9 -763.9 963.7 -1,536 -1,214
Operating Margin - -53,920.71% -6,638.4% 29.37% -420.85% -311.54%
Earnings before Tax (EBT) 1 -476.3 -617.7 -674.3 1,410 -1,475 -1,160
Net income 1 -476.3 -617.7 -674.3 1,410 -1,475 -1,160
Net margin - -55,153.39% -5,859.74% 42.98% -403.95% -297.68%
EPS 2 -2.138 -2.675 -2.432 4.437 -4.560 -3.533
Free Cash Flow 1 -225.3 -296.5 -555.4 -288.4 -744.2 -164.3
FCF margin - -26,476.94% -4,826.2% -8.79% -203.88% -42.17%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/29/19 3/31/20 3/11/21 3/11/22 3/15/23 3/15/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2
Net sales 1 - -
EBITDA 1 -192.1 -323.6
EBIT 1 -224.6 -356.4
Operating Margin - -
Earnings before Tax (EBT) 1 -212.2 -313.5
Net income 1 -212.2 -313.5
Net margin - -
EPS 2 -0.6500 -0.9600
Dividend per Share - -
Announcement Date 5/15/23 8/14/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 334 - - - -
Net Cash position 1 196 - 1,545 2,047 2,281 1,783
Leverage (Debt/EBITDA) - -0.6715 x - - - -
Free Cash Flow 1 -225 -297 -555 -288 -744 -164
ROE (net income / shareholders' equity) -30.4% -41.5% -29.9% 36.1% -30.4% -26.1%
ROA (Net income/ Total Assets) -13.5% -16.9% -16.6% 13.7% -15.2% -11.3%
Assets 1 3,530 3,650 4,073 10,290 9,711 10,274
Book Value Per Share 2 6.990 5.910 10.00 14.80 15.30 11.70
Cash Flow per Share 2 0.9400 1.770 5.370 4.370 3.670 4.240
Capex 1 35.9 117 53.2 134 139 38.7
Capex / Sales - 10,472.68% 462.05% 4.07% 38.13% 9.93%
Announcement Date 3/29/19 3/31/20 3/11/21 3/11/22 3/15/23 3/15/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
MEDIGEN VACCINE BIOLOGICS CORPORATION Stock Medigen Vaccine Biologics Corporation
-26.82% 517M
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-8.42% 8.12B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 6547 Stock
  4. Financials Medigen Vaccine Biologics Corporation